HARP News and Press, Harpoon Therapeutics Inc. From 05/22/20

SOUTH SAN FRANCISCO, Calif., May 22, 2020 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, announced today that interim Phase 1 data for HPN424 for prostate cancer will be presented at the Amer...

Harpoon Therapeutics (NASDAQ: HARP ): Q1 GAAP EPS of -$0.51 misses by $0.16 . More news on: Harpoon Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Dosed first patient with HPN217 for the treatment of multiple myeloma, triggering a $50 million milestone payment from AbbVie Abstract for HPN424 interim Phase 1 data accepted for presentation at ASCO20 Virtual SOUTH SAN FRANCISCO, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- Harpoon...

Thinly traded micro cap Harpoon Therapeutics ( HARP +8.6% ) is up average volume in reaction to its announcement that the first patient has been dosed in a Phase 1/2 clinical trial evaluating candidate HPN217 in patients with relapsed/refractory multiple myeloma. More news on: Harpoo...

SOUTH SAN FRANCISCO, Calif., April 27, 2020 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that the first patient has been dosed with HPN217 in a Phase 1/2 clinical trial focu...

Amid widespread uncertainty in healthcare around COVID-19 impact, Baird is focusing on clinical catalysts that continue to power biotech picks - and in particular it's declaring fresh picks on two stocks with data forthcoming. More news on: Constellation Pharmaceuticals, Inc., Blueprint Me...

Andrew R. Robbins, former Chief Operating Officer, Array Biopharma Dr. Joseph S. Bailes, former President of American Society of Clinical Oncology (ASCO) SOUTH SAN FRANCISCO, Calif., April 01, 2020 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immuno...

A string of scientific breakthroughs in recent years has made oncology the most-watched corner of the biopharmaceutical industry, and many of those breakthroughs were first presented at the American Society of Clinical Oncology's (ASCO) annual meeting. However, gathering scientists from all ove...

The following medical companies have filed for mixed shelf offerings: More news on: iBio, Inc., Verrica Pharmaceuticals Inc., Inovio Pharmaceuticals, Inc., Healthcare stocks news, , Read more ...

The following slide deck was published by Harpoon Therapeutics, Inc. in conjunction with their 2019 Q4 earnings Read more ...